Medications for Postacute Covid19 Syndrome

4 results

  • Aldactazide (spironolactone and hydrochlorothiazide)

    (spironolactone and hydrochlorothiazide)
    Pfizer Laboratories Div Pfizer Inc
    Usage: ALDACTAZIDE is indicated for managing edematous conditions in congestive heart failure, cirrhosis with edema, nephrotic syndrome, and for treating essential hypertension. It is also used for diuretic-induced hypokalemia when other therapies are inadequate. Routine diuretic use during pregnancy is inappropriate unless due to pathological causes.

  • Famotidine (famotidine)

    (Famotidine)
    Denton Pharma, Inc. DBA Northwind Pharmaceuticals
    Usage: Famotidine tablets are indicated for treating active duodenal and gastric ulcers, symptomatic non-erosive GERD, erosive esophagitis from GERD, and pathological hypersecretory conditions in adults. They also reduce the risk of duodenal ulcer recurrence in adults and pediatric patients 40 kg and above.

  • Ranitidine (ranitidine hydrochloride)

    (RANITIDINE HYDROCHLORIDE)
    WOCKHARDT LIMITED
    Usage: Ranitidine Tablets are indicated for short-term treatment of active duodenal and gastric ulcers, maintenance therapy post-healing, treatment of GERD, pathological hypersecretory conditions, and erosive esophagitis. They provide symptomatic relief within 24 hours and are used alongside antacids for pain management.

  • Ranitidine (ranitidine)

    (ranitidine)
    Wockhardt USA LLC.
    Usage: Ranitidine Tablets are indicated for the short-term treatment of active duodenal and gastric ulcers, GERD, and erosive esophagitis, as well as maintenance therapy post-healing. It is also used for pathological hypersecretory conditions such as Zollinger-Ellison syndrome. Symptomatic relief typically occurs within 24 hours for GERD and esophagitis.